Common Equity: The sum of all common equity items.
ADMA Biologics Inc (ADMA) had Common Equity of $477.32M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$139.16M |
|
$49.38M |
|
$50.35M |
|
$88.81M |
|
$76.41M |
|
$62.75M |
|
$-1.16M |
|
$61.59M |
|
$61.59M |
|
$49.38M |
|
$49.38M |
|
$49.38M |
|
$49.38M |
|
$62.75M |
|
$64.96M |
|
238.30M |
|
244.91M |
|
$0.22 |
|
$0.20 |
|
| Balance Sheet Financials | |
$466.51M |
|
$65.06M |
|
$157.73M |
|
$624.24M |
|
$69.54M |
|
$75.98M |
|
$77.38M |
|
$146.92M |
|
|
Common Equity |
$477.32M |
$473.16M |
|
$477.32M |
|
237.87M |
|
| Cash Flow Statement Financials | |
$50.40M |
|
$-21.89M |
|
$-44.02M |
|
$103.15M |
|
$87.63M |
|
$-15.52M |
|
$20.03M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.71 |
|
-- |
|
-- |
|
0.14 |
|
0.17 |
|
63.82% |
|
45.09% |
|
45.09% |
|
-- |
|
44.26% |
|
35.48% |
|
$27.82M |
|
-- |
|
-- |
|
-- |
|
0.22 |
|
0.24 |
|
0.88 |
|
102.46 |
|
10.35% |
|
10.44% |
|
7.91% |
|
8.92% |
|
$2.01 |
|
$0.11 |
|
$0.21 |
|